CDT Equity Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K covers events occurring on August 31, 2026, for CDT Equity Inc., a Delaware corporation trading on The Nasdaq Stock Market under the symbols CDT (Common Stock) and CDTTW (Redeemable Warrants). The filing details the entry into material definitive agreements regarding an equity investment and short-term financing.
Key Financial Metrics and Transactions
- Equity Investment Amendment: The Company amended its agreement to acquire a 20% equity interest in Sarborg Limited for a total consideration of $8,000,000.
- Stock Issuance: On August 31, 2026, the Company issued 650,000 shares of Common Stock to Sarborg Limited to partially satisfy the $1,750,000 portion of the consideration payable in stock.
- Debt Financing: The Company issued a senior secured convertible promissory note to J.J. Astor & Co. with a principal amount of $541,620. Net proceeds received were $375,002 after closing fees.
- Debt Repayment: The note issued on August 31, 2026, was repaid in full on September 4, 2026.
- Warrants Issued: In connection with the note, the Company issued warrants to purchase 237,000 shares of Common Stock at an exercise price of $1.69 per share, expiring five years from issuance.
Material Changes and Payment Terms
The filing outlines significant changes to the payment structure for the Sarborg acquisition and the execution of a short-term bridge loan:
- Sarborg Payment Structure: The remaining cash consideration for the Sarborg acquisition is to be funded via the Company's at-the-market (ATM) program. The Company committed to minimum monthly payments of $150,000, with the full balance due by May 31, 2027. Audit costs for Sarborg's fiscal years 2024, 2025, and pro-forma 2026 will be credited against the cash owed.
- ATM Proceeds Allocation: Ninety percent (90%) of net proceeds from the existing ATM program were directed to repay the J.J. Astor & Co. note until it was satisfied in full.
- Conversion Terms: The note included a conversion feature at 70% of the 20-day VWAP or a floor price of $0.338, subject to a 4.99% beneficial ownership limit. No conversion occurred as the note was repaid in cash.
Outlook, Risks, and Contingencies
- Stockholder Approval Requirement: If the exercise of the J.J. Astor & Co. warrants results in the issuance of shares exceeding 19.99% of the outstanding Common Stock, stockholder approval is required under Nasdaq rules. The Company agreed to convene a meeting if requested by the lender, no later than October 31, 2026.
- Liquidity Management: The Company is utilizing its ATM program to service both the Sarborg acquisition debt and the short-term note, indicating reliance on equity markets for liquidity.
- Unregistered Sales: The issuance of the Sarborg shares, the note, and the warrants relied on the Section 4(a)(2) exemption from registration under the Securities Act of 1933.
Investor Verification Checklist
- Verify the current outstanding balance of the $8,000,000 Sarborg acquisition consideration and the status of the $150,000 monthly payment schedule.
- Confirm the total number of outstanding Common Stock shares to assess the dilution impact of the 650,000 Sarborg shares and potential 237,000 warrant shares.
- Review the Company's remaining capacity under its at-the-market (ATM) offering program to ensure it can meet the May 31, 2027, payment deadline for Sarborg.
- Monitor for any stockholder meeting notices regarding the potential approval of warrant exercises exceeding the 19.99% threshold.